Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

AMAG’s Makena fails to achieve primary objectives in PROLONG trial

PROLONG trial was conducted in around 1,700 pregnant women. Credit: Heather Mount on Unsplash.



  • AMAG’s Makena fails PROLONG trial

Go Top